The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease

NCT04792580 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Graft-versus-host-disease
Ocular Graft-versus-host Disease

Interventions

DRUG: Lifitegrast 5% Ophthalmic Solution
DRUG: Placebo

Sponsor

Richard W Yee, MD

Collaborators

[object Object]